Participant, Site Personnel and Sponsor Perspectives on Decentralized Trial Features in COURAGE-ALS: a Randomized Clinical Trial

Hospitalizations as an Outcome Measure in COURAGE-ALS

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

Plasma Neurofilament Analysis in VITALITY-ALS

Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial

Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness

Tirasemtiv Enhances Submaximal Muscle Tension in an Acta1:p.Asp286Gly Mouse Model of Nemaline Myopathy

Feasibility Assessment of Using the MiToS Staging System for Conducting Economic Evaluation in Amyotrophic Lateral Sclerosis